Gilead Sciences
GILD
#111
Rank
HK$1.423 T
Marketcap
HK$1,148
Share price
0.49%
Change (1 day)
31.07%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): HK$57.94

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is HK$58.21. In 2025 the company made an earnings per share (EPS) of HK$53.74 an increase over its 2024 EPS that were of HK$2.98.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$57.947.82%
2025HK$53.741702.63%
2024HK$2.98-91.65%
2023HK$35.6923.98%
2022HK$28.79-25.86%
2021HK$38.834850%
2020HK$0.78-97.64%
2019HK$33.260.9%
2018HK$32.9718.71%
2017HK$27.77-64.88%
2016HK$79.07-18.45%
2015HK$96.9655.28%
2014HK$62.44296.02%
2013HK$15.7717.89%
2012HK$13.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.52 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.28-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.14-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.42 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.59 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$73.35 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$43.38-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$133.44 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.04-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA